Purchase Order HT941025P0022

The Defense Health Agency (DHA) awarded a firm-fixed-price purchase order contract to Medpharm, Inc. (doing business as Procara), a minority-owned small disadvantaged business, to provide coagulation reagents, consumables, maintenance, and the lease of Stago Compact MAX3 laboratory analyzers for the U.S. Naval Hospital Guam. The $1,458,999.31 contract has a period of performance from January 1, 2025 through September 30, 2029, with four one-year option periods. This award was a total small business set-aside, reflecting Procara's status as a self-certified Small Disadvantaged Business and Asian-Pacific American Owned enterprise. The contract supports the DHA's mission to provide medical readiness and healthcare services to U.S. armed forces, particularly in the Pacific region.